Eagle Claw Capital Managment, LLC Collegium Pharmaceutical, Inc Transaction History

Eagle Claw Capital Managment, LLC

  • $573 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 18, 2019
SELL
$10.62 - $16.59 $115,226 - $180,001
-10,850 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$13.58 - $18.72 $147,343 - $203,112
10,850 New
10,850 $164,000
Q3 2018

Nov 14, 2018
SELL
$14.16 - $24.3 $121,776 - $208,980
-8,600 Closed
0 $0
Q1 2018

May 18, 2018
BUY
$18.15 - $29.21 $156,090 - $251,206
8,600 New
8,600 $220,000

Others Institutions Holding COLL

# of Institutions
255
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email